{'fraction_non_alphanumeric': 0.042735042735042736, 'fraction_numerical': 0.004884004884004884, 'mean_word_length': 4.616438356164384, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 1, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Fatal e-cigarette or vaping associated lung injury (EVALI): a first case report in Europe

Numerous cases of e-cigarette, or vaping, associated lung injury (EVALI) have recently prompted an investigation of the outbreak in the USA [1]. Only two non-fatal cases have been reported so far in Europe: one case of hypersensitivity pneumonia in the UK after the use of flavoured e-cigarette liquid by a young adolescent [2], and one US imported case recently described in Spain [3]. To our knowledge, this is the first report of a fatal EVALI case in Europe. Numerous cases of e-cigarette or vaping associated lung injury (EVALI) have been described, mainly in the US and Canada. However, public health and medical communities need to be aware that this deadly disease may occur outside North America. https://bit.ly/2UzZJpI